681 related articles for article (PubMed ID: 34977872)
1. Targeting DNA repair pathway in cancer: Mechanisms and clinical application.
Wang M; Chen S; Ao D
MedComm (2020); 2021 Dec; 2(4):654-691. PubMed ID: 34977872
[TBL] [Abstract][Full Text] [Related]
2. Clinical translation for targeting DNA damage repair in non-small cell lung cancer: a review.
Mao X; Lee NK; Saad SE; Fong IL
Transl Lung Cancer Res; 2024 Feb; 13(2):375-397. PubMed ID: 38496700
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in DDR (DNA damage response) inhibitors for cancer therapy.
Cheng B; Pan W; Xing Y; Xiao Y; Chen J; Xu Z
Eur J Med Chem; 2022 Feb; 230():114109. PubMed ID: 35051747
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic based synthetic lethal strategies in human cancers.
Gao A; Guo M
Biomark Res; 2020; 8():44. PubMed ID: 32974031
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Targeting of DNA Damage Response in Cancer.
Choi W; Lee ES
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163621
[TBL] [Abstract][Full Text] [Related]
6. Targeting the DNA damage response for patients with lymphoma: Preclinical and clinical evidences.
Carrassa L; Colombo I; Damia G; Bertoni F
Cancer Treat Rev; 2020 Nov; 90():102090. PubMed ID: 32892059
[TBL] [Abstract][Full Text] [Related]
7. DNA damage response inhibitors: An avenue for TNBC treatment.
Jin J; Tao Z; Cao J; Li T; Hu X
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188521. PubMed ID: 33556453
[TBL] [Abstract][Full Text] [Related]
8. Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment.
Maresca L; Stecca B; Carrassa L
Cells; 2022 Apr; 11(9):. PubMed ID: 35563772
[TBL] [Abstract][Full Text] [Related]
9. Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.
Gourley C; Balmaña J; Ledermann JA; Serra V; Dent R; Loibl S; Pujade-Lauraine E; Boulton SJ
J Clin Oncol; 2019 Sep; 37(25):2257-2269. PubMed ID: 31050911
[TBL] [Abstract][Full Text] [Related]
10. State-of-the-art strategies for targeting the DNA damage response in cancer.
Pilié PG; Tang C; Mills GB; Yap TA
Nat Rev Clin Oncol; 2019 Feb; 16(2):81-104. PubMed ID: 30356138
[TBL] [Abstract][Full Text] [Related]
11. Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.
Basourakos SP; Li L; Aparicio AM; Corn PG; Kim J; Thompson TC
Curr Med Chem; 2017; 24(15):1586-1606. PubMed ID: 27978798
[TBL] [Abstract][Full Text] [Related]
12. Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors.
Gachechiladze M; Skarda J; Bouchalova K; Soltermann A; Joerger M
Front Oncol; 2020; 10():581217. PubMed ID: 33224881
[TBL] [Abstract][Full Text] [Related]
13. Could Inhibiting the DNA Damage Repair Checkpoint Rescue Immune-Checkpoint-Inhibitor-Resistant Endometrial Cancer?
Li Y; Wang X; Hou X; Ma X
J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109350
[TBL] [Abstract][Full Text] [Related]
14. Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells.
Takeuchi M; Tanikawa M; Nagasaka K; Oda K; Kawata Y; Oki S; Agapiti C; Sone K; Miyagawa Y; Hiraike H; Wada-Hiraike O; Kuramoto H; Ayabe T; Osuga Y; Fujii T
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31805725
[No Abstract] [Full Text] [Related]
15. Targeting DNA Damage Repair and Immune Checkpoint Proteins for Optimizing the Treatment of Endometrial Cancer.
Bian X; Sun C; Cheng J; Hong B
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765210
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors.
Clark CA; Yang ES
J Immunother Precis Oncol; 2023 Feb; 6(1):31-49. PubMed ID: 36751656
[TBL] [Abstract][Full Text] [Related]
17. ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells.
Ronco C; Martin AR; Demange L; Benhida R
Medchemcomm; 2017 Feb; 8(2):295-319. PubMed ID: 30108746
[TBL] [Abstract][Full Text] [Related]
18. Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies.
Minchom A; Aversa C; Lopez J
Ther Adv Med Oncol; 2018; 10():1758835918786658. PubMed ID: 30023007
[TBL] [Abstract][Full Text] [Related]
19. DNA Damage Repair Inhibitors-Combination Therapies.
Smith G; Alholm Z; Coleman RL; Monk BJ
Cancer J; 2021 Nov-Dec 01; 27(6):501-505. PubMed ID: 34904813
[TBL] [Abstract][Full Text] [Related]
20. Targeting DNA Damage Repair Pathways in Pancreatic Adenocarcinoma.
Das S; Cardin D
Curr Treat Options Oncol; 2020 Jun; 21(8):62. PubMed ID: 32601814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
